Identification of a Proline-rich Akt Substrate As a 14-3-3 Binding Partner
Overview
Authors
Affiliations
Akt (also called protein kinase B) is one of the major downstream targets of the phosphatidylinositol 3-kinase pathway. This protein kinase has been implicated in insulin signaling, stimulation of cellular growth, and inhibition of apoptosis as well as transformation of cells. Although a number of cellular proteins have been identified as putative targets of the enzyme, additional substrates may play a role in the varied responses elicited by this enzyme. We have used a combination of 14-3-3 binding and recognition by an antibody to the phosphorylation consensus of the enzyme to identify and isolate one of the major substrates of Akt, which is also a 14-3-3 binding protein. This 40-kDa protein, designated PRAS40, is a proline-rich Akt substrate. Demonstration that it is a substrate of Akt was accomplished by showing that 1) PRAS40 was phosphorylated in vitro by purified Akt on the same site that was phosphorylated in insulin-treated cells; 2) activation of an inducible Akt was alone sufficient to stimulate the phosphorylation of PRAS40; and 3) cells lacking Akt1 and Akt2 exhibit a diminished ability to phosphorylate this protein. Thus, PRAS40 is a novel substrate of Akt, the phosphorylation of which leads to the binding of this protein to 14-3-3.
Pleiotropic tumor suppressive functions of PTEN missense mutations during gliomagenesis.
Jun H, Paulo J, Appleman V, Yaron-Barir T, Johnson J, Yeo A iScience. 2024; 27(12):111278.
PMID: 39660053 PMC: 11629276. DOI: 10.1016/j.isci.2024.111278.
AKT kinases as therapeutic targets.
Hassan D, Menges C, Testa J, Bellacosa A J Exp Clin Cancer Res. 2024; 43(1):313.
PMID: 39614261 PMC: 11606119. DOI: 10.1186/s13046-024-03207-4.
Al-Othman R, Al-Jarallah A, Babiker F Front Pharmacol. 2024; 15:1398630.
PMID: 39611167 PMC: 11603114. DOI: 10.3389/fphar.2024.1398630.
Targeting the mTOR-Autophagy Axis: Unveiling Therapeutic Potentials in Osteoporosis.
Chen R, Yang C, Yang F, Yang A, Xiao H, Peng B Biomolecules. 2024; 14(11).
PMID: 39595628 PMC: 11591800. DOI: 10.3390/biom14111452.
Mutant-selective AKT inhibition through lysine targeting and neo-zinc chelation.
Craven G, Chu H, Sun J, Carelli J, Coyne B, Chen H Nature. 2024; 637(8044):205-214.
PMID: 39506119 DOI: 10.1038/s41586-024-08176-4.